MedTrace Logo

Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis

NCT00215059 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-08-02

No results posted yet for this study

Summary

Prospective, single center, descriptive study in 14 infants/children with multivessel pulmonary vein stenosis stratified for patients with or without underlying cardiac disease.

Group 1: Patients without additional structural heart disease and multivessel pulmonary vein stenosis.

Group 2: Patients with additional structural heart disease and multivessel pulmonary vein stenosis.

Conditions

  • Multivessel Pulmonary Vein Stenosis

Sponsors & Collaborators

Principal Investigators

  • Mark W Kieran, MD,PhD · Dana-Farber Cancer Institute

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-08-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00215059 on ClinicalTrials.gov